Herpes zoster and herpes simplex--public health matter; chelatotherapy in these acute neuroviroses.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use / Q000633:toxicity; D002125:Calcium Gluconate / Q000627:therapeutic use / Q000633:toxicity; D002614:Chelating Agents / Q000627:therapeutic use / Q000633:toxicity; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003545:Cysteine / Q000627:therapeutic use / Q000633:toxicity; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations / Q000627:therapeutic use / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D004492:Edetic Acid / Q000627:therapeutic use / Q000633:toxicity; D005260:Female; D006561:Herpes Simplex / Q000188:drug therapy*; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D008297:Male; D051381:Rats; D012008:Recurrence; D013997:Time Factors
D000998:Antiviral Agents; D002614:Chelating Agents; D004338:Drug Combinations; C044148:rodilemid; D004492:Edetic Acid; D003545:Cysteine; D002125:Calcium Gluconate